Trially CEO Kyle McAllister explains why transparent AI reasoning is essential for trial patient matching.
Kyle McAllister
Advertisement
Kyle McAllister is the Co-Founder and CEO of Trially, a Kansas City-based company building AI-driven technology that matches, contacts, and enrolls patients in clinical trials. Before launching Trially in 2023, he spent years in healthcare IT and clinical research, including as VP of Data & Analytics at Cognitive Clinical Trials and Director of Data Analytics at Pivot Point Consulting, where he also worked as a senior consultant. His background also includes population health strategy work at Nordic Consulting Partners. Kyle holds a BS in Management and Entrepreneurship from the University of Arizona and an MBA from the University of Missouri-Kansas City.
Articles by Kyle McAllister
Trially Co-founder and CEO Kyle McAllister, explains how AI absorbing the bulk of clinical-trial chart reviews can free research sites to focus staff time on higher-value tasks.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Real-Time Clinical Trials Depend on a Scalable EHR-to-EDC Connection
2
FDA Launches Rare Disease Framework Initiative to Reimagine Drug Development for Small Patient Populations
3
What It Actually Means to Embed AI Across the Clinical Operating Model
4
The Human Side of Clinical Trials: Why Fuzzy Mental Models Undermine Clinical Trial Execution
5